West Virginia 2022 Regular Session

West Virginia House Bill HB2182

Introduced
1/12/22  

Caption

Relating to the Ryan Brown Fund

Impact

The bill specifically outlines how the Ryan Brown Fund should be financed, requiring that settlements from drug manufacturers and other relevant parties be redirected into this fund. This provision aims to ensure a consistent funding stream for treatment services, expanding the accessibility of treatment and recovery programs. The targeted allocation of resources to licensed facilities to provide comprehensive treatment, including inpatient and outpatient services, seeks to address the pressing public health crisis surrounding substance abuse and addiction in the state, influencing existing health care laws and regulations.

Summary

House Bill 2182 aims to amend the Code of West Virginia to enhance the Ryan Brown Fund, which is dedicated to providing support for children suffering from Neonatal Abstinence Syndrome (NAS) and improving substance use disorder treatment across the state. It stipulates that the Secretary of the Department of Health and Human Resources must identify and allocate funds to facilities that provide these critical health services, thereby directing resources to where the state perceives the greatest need. This will not only help infants affected by NAS but also fund broader substance use disorder treatment programs designed to help various demographics in West Virginia.

Sentiment

The sentiment surrounding HB 2182 appears to be largely supportive among health advocates and lawmakers focused on addressing the substance abuse crisis. Proponents see the bill as a crucial step toward improving health outcomes for vulnerable populations, particularly infants facing severe health challenges due to prenatal substance exposure. However, as with many legislation concerning health care funding, there may be concerns regarding the adequacy of funding and the effectiveness of the treatment services provided under this new directive.

Contention

Notably, discussions around HB 2182 may encompass varying opinions on how health care funding should be prioritized and managed. Critics could argue that while the bill addresses immediate needs, it may fall short of providing long-term solutions necessary for tackling the broader substance abuse problem in West Virginia. Questions may also arise regarding the effectiveness of the established programs funded through the Ryan Brown Fund, with some fearing that without proper oversight, funds may not yield the intended positive impact.

Companion Bills

No companion bills found.

Similar Bills

CA AB1098

Recovery residences.

LA HB595

Creates and provides for the Task Force on Opioid Use Prevention, Treatment, and Recovery

WV SB582

Creating WV Workforce Resiliency Act

CA SB554

Nurse practitioners: physician assistants: buprenorphine.

CA AB1136

Health facilities: residential mental health or substance use disorder treatment.

KY HB776

AN ACT relating to controlled substances.

CA AB682

Health facilities: residential mental health or substance use disorder treatment.

CA AB541

Tobacco assessment.